Navelbine and renal failure acute Patient Reports February 11, 2012

Navelbine Side Effects Report #5851903-2
Navelbine side effect was reported by a Consumer or non-health professional from GREECE on Aug 04, 2008. Male patient, 56 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: ascites, nephropathy toxic, performance status decreased, pleural effusion, renal failure acute. Navelbine dosage: 30 MG/M2, CYCLICAL INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient recovered.

Navelbine Side Effects Report #6003751-0
Navelbine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 28, 2008. Female patient, 63 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: renal failure acute, vasculitis . Navelbine dosage: 38 MG IV. During the same period patient was treated with CISPLATIN, CEFTRIAXONE, CIPROFLOXACIN, CLARITHROMYCIN, DEXAMETHASONE, GENTAMICIN, PIPERACILLIN. Patient was hospitalized and became disabled. Patient recovered.

Navelbine Side Effects Report #6133802-4
Navelbine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 09, 2009. Female patient, 63 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: rash , renal failure acute, vasculitis . Navelbine dosage: 38 MG IV. During the same period patient was treated with CISPLATIN, CEFTRIAXONE, CIPROFLOXACIN, CLARITHROMYCIN, DEXAMETHASONE, GENTAMICIN, PIPERACILLIN W. Patient was hospitalized and became disabled. Patient recovered.

Navelbine Side Effects Report #5470349-2
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 03, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: renal failure acute. Navelbine dosage: 25 MG IV. During the same period patient was treated with GEMCITABINE. Patient recovered.


Navelbine Side Effects Report #5722910-5
Navelbine side effect was reported by a Health Professional from FRANCE on Apr 10, 2008. Male patient was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: renal failure acute, renal tubular necrosis. Navelbine dosage: 60 MG QD IV. During the same period patient was treated with CISPLATIN, TAHOR, BIPRETERAX, FUROSEMIDE, ATARAX, TRAMADOL, EMEND, SOLUPRED. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5632997-6
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 25, 2008. Female patient, 67 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haematocrit decreased, leukopenia, metastases to bone, red blood cell count decreased, renal failure acute, thrombocytopenia. Navelbine dosage: 0 MG/M2 QD IV. Patient died on 12/29/2007.

Navelbine Side Effects Report #5647196-1
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 25, 2008. Female patient, 67 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, leukopenia, metastases to bone, renal failure acute, thrombocytopenia. Navelbine dosage: 0 MG/M2 QD IV. Patient died on 12/29/2007.

Navelbine Side Effects Report #5842935-9
Navelbine side effect was reported by a Physician from SPAIN on July 08, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: diarrhoea, metabolic acidosis, neutropenia, renal failure acute, septic shock, syncope. Navelbine dosage: 25 MG/M2; CYCLICAL. During the same period patient was treated with CAPECITABINE. Patient died.